Contact Form

Name

Email *

Message *

Monday, 1 February 2021

Google Lens to get offline translation support for Android users: Report

Google had unveiled the Google Lens back in 2017, which initially was reserved just for Pixel phones. Google is now rolling out an update for Google Lens that will allow it to translate text in offline mode. Until now the translation feature was just an online feature in smartphones. Google had been working on the offline mode feature for a while and has now started rolling out the new update that wherein Lens for Android can translate text in offline mode. This story is available on the XDA Developers website.

Google-Lens

Google has commenced with the rollout of Offline Translation of Google Lens for Android users that could take a few days to reach everyone.

On receiving the update, users will get to see a new “Tap to download”  that will download the respective language pack for offline translations. Once the language is downloaded, users will see a checkmark next to the language, indicating that it is ready for offline translations. Tapping on the checkmark again will remove the language pack from your device, so try not to tap again. As soon as the download is complete the Google Lens app on Android devices will start translating text even without an internet connection.

It will work like an “Instant” feature, which means that the app will automatically translate to your preferred language as soon as the camera is pointed at the text.

Users won't be required to tap on the shutter button for capturing a still shot. As soon as it is done, users will get a preview window with the translation on the live preview.

The preview also gets a “Copy all” button to help users quickly copy the translated text onto the clipboard.

To use the Offline translate in Lens, users will be required to have the latest version of the Google app on their devices.



from Firstpost Tech Latest News https://ift.tt/3pBqtEB

WHO team investigates the origins of COVID-19 in China, one year later

After a two-week quarantine, the real work can begin. Maybe. A World Health Organization team of researchers has emerged from their hotel for the first time since their arrival in the central Chinese city of Wuhan to start searching for clues into the origins of the COVID-19 pandemic. The visit has been shrouded in secrecy: The WHO tweeted Thursday a few details of what they will do, but it’s unknown how much access China will give the researchers to the sites they want to visit and the people they want to talk to.

Ken Maeda, center of the World Health Organization team prepares to leave for a third day of field visit in Wuhan in central China's Hubei province on Sunday, Jan. 31, 2021. Image credit: AP Photo/Ng Han Guan)

Why is the team in China?

Scientists hope that information on the earliest known cases of the new coronavirus — which was first identified in Wuhan — will help them better understand where it came from and prevent similar pandemics in the future.

Researchers around the world are eager for access to samples taken from the Huanan Seafood Market, which had an early outbreak, and Wuhan hospital records.

The WHO said in its tweets that the team would meet with Chinese scientists on Friday before starting field visits in and around Wuhan. It plans to visit hospitals, laboratories and markets, including the Wuhan Institute of Virology, the Huanan market and the Wuhan Center for Disease Control laboratory, the WHO said. It said the team would speak with early responders and some of the first patients.

A laboratory at the Wuhan Institute of Virology that was built after the 2003 SARS pandemic maintains an extensive archive of genetic sequences of bat coronaviruses. U.S. officials in the previous Trump administration suggested without offering evidence that the virus could have escaped from the institute.

Experts say it’s unlikely the new coronavirus emerged from the lab in Wuhan and overwhelmingly say analysis of the new coronavirus’s genome rules out the possibility that it was engineered by humans.

The market and other places where early cases emerged remain important because the virus is constantly evolving, as the new variants identified in the United Kingdom and South Africa show.

What do researchers hope to learn?

Wuhan is where COVID-19 cases were first detected, but it is highly possible the virus came to the industrial city of 11 million people from elsewhere.

Genetic sequencing shows the new coronavirus started in bats and likely jumped to another animal before infecting humans. The virus that is the closest known relative of the one that causes COVID-19 has been found in bats in a mine shaft nearly 1,000 miles (1,600 kilometers) southwest of Wuhan, near China’s border with Laos, Myanmar and Vietnam. The Associated Press was blocked from visiting the mine.

People began falling ill in Wuhan in December 2019, and many had links to the seafood market. Scientists initially suspected the virus came from wild animals sold at the market, prompting China to crackdown on the wildlife trade.

But the subsequent discovery of earlier cases challenged that theory. China’s CDC said samples taken from the market indicate it was likely a place where the virus spread, not where it started. The WHO team’s ability to further our understanding of the virus — and its credibility — could hinge in part on getting access to those samples.

Studying the genes of the earliest known cases in Wuhan could provide clues to how it got from bats to people and whether it was through a mammal such as a bamboo rat or a civet.

What obstacles does the team face?

The big question is what China will allow the researchers to see and do. The ruling Communist Party is concerned the research could shed light on its handling of the virus that could open it up to international criticism — and even demands for financial compensation if it is found to have been negligent.

China has stifled independent reports about the outbreak at home and published little information on its research into the origins of the virus. An AP investigation found that the government has strictly controlled all COVID-19-related research and forbids researchers from speaking to the media.

Another AP investigation found WHO officials privately complained that China had dragged its feet on sharing critical information about the outbreak, including the new virus’s genetic sequence, even as the U.N. health agency publicly praised China for what it called a speedy response.

China, stung by complaints it allowed the disease to spread, has suggested the virus could have come from abroad. A government spokesperson has said the origins hunt will require work beyond China’s borders, including in bat habitats in Southeast Asian nations. An expert on the WHO team has suggested the same thing, and this is a possibility researchers are exploring.

When will know the answers?

The search for the origins of COVID-19 is likely to take years. It took more than a decade to find the origins of SARS, and the origins of Ebola, first identified in the 1970s, remain elusive. But knowing where the virus came from could help prevent future outbreaks of viruses that cross to people from wild animals.



from Firstpost Tech Latest News https://ift.tt/2YKQZzT

Tata Tiago Limited Edition variant launched in India at 5.79 lakh: All you need to know

Tata Motors unveils a new variant of its popular hatchback Tata Tiago. The new hatchback is called the Tiago Limited Edition that celebrates the first anniversary of the Tiago refresh range. The Tiago Limited Edition details are available on the company website. Tata Motors has launched the limited edition Tata Tiago t a price of Rs 5.79 lakh (ex-showroom Delhi). The car is based on the XT trim and uses the same peppy design as the standard model with a range of style updates as well as comfort and convenience features.

Tiago-1280

The car is available in colour options of Flame Red, Pearlescent White, and Daytona Grey. One of the significant features includes the 14-inch black finished alloy wheels giving it a more sporty character.

The Tiago Limited Edition gets a 7-inch touchscreen infotainment system and features 3D navigation through Navimaps along with support for voice commands that can be used for various range of features. For safety, the Tiago Limited Edition will come with parking assist with the display.

On the exterior, the features remain more or less the same, like the angular headlamps, dual-tone bumper, chrome garnished fog lamps, side character lines, sculpted hood, boomerang styled tail lamps, and rear spoiler.

Tata Tiago Limited Edition engine

Tiago Limited Edition sports a 1.2-liter Revotron petrol engine that makes 86 ps of max power at 6,000 rpm and 113 Nm of max torque at 3,300 rpm. The engine comes mated with a 5-speed manual transmission and misses out on the AMT option.

The car continues to have its safety advantages, being the safest car in its class wherein the car had received a 4-star safety rating in crash tests conducted by Global NCAP.

Some standard safety features of the new Tiago Limited Edition include ABS with EBD, driver and co-driver airbag, speed sensing auto door lock, corner stability control, immobilizer,  rear smart wiper and wash, over-speed alert, follow me home lamps, and day & night inside rearview mirror.



from Firstpost Tech Latest News https://ift.tt/3rfOCRP

TATA, CSIR in talks with Moderna to conduct trials, bring COVID-19 vaccine to India

TATA Group's newly launched medical venture Tata Medical & Diagnostics is reportedly in talks with Moderna to bring its COVID-19 vaccine to India after conducting clinical trials to ensure its safety and efficacy. The Economic Times reported that the dialogue is still in its early days and that sources have said that the company would partner up with the Council of Scientific & Industrial Research (CSIR) to carry out the necessary clinical trials of Moderna’s vaccine candidate in India.

The Director-General of CSIR Shekhar C Mande told The Print, "We are in talks with Moderna to understand the science behind their vaccine and how it works on the human body. Till now, the discussions are scientific in nature".

The Centre for Cellular and Molecular Biology (CCMB) in Hyderabad has the capacity to develop this vaccine very quickly – within weeks, Mande said.

When asked about Indian pharma companies interested in, Mande said “I don’t know if Wockhardt has shown interests or even if Tata Sons has pitched in. We have worked with Tata Sons in the past. We will be delighted if they are interested to take part in this. Also, IIL could work.”

So even though Moderna's vaccine has been approved by the US, UK and France and is being used in inoculation drives around the world, it is still important that the vaccine is tested in India. This is because not everyone will respond to a vaccine in the same way and that applies to people from the same race and even more so for people from different races. Health authorities need country-specific data to give their approvals and ensure the vaccine will not have any adverse effects on their people.

The bridge trial, as it is called, gives a country access to a vaccine that otherwise would've taken a long time to reach them. This is an important aspect especially in a crisis situation like COVID-19.

This is also the reason Russia's COVID-19 vaccine Sputnik V needs to complete a Phase 3 trial and have partnered up with Hyderabad's pharma company Dr Reddy's and why AstraZeneca tied up with Serum Institute of India to conduct the Oxford vaccine trials and produce it in India. Johnson & Johnson have also tied up Biological E to conduct a trial in India.

The other reason, according to a Reuters report, is that India has made it mandatory for any vaccine maker to conduct a clinical trial in the country before it will get a chance to be approved.

According to the ET report, "exploratory talks have started between Tata Medical & Diagnostics and Moderna and concrete plans will be finalised once government approvals for private sector participation come in".

India has approved two COVID-19 vaccines – Bharat Biotech's Covaxin and Serum Institute of India's Covishield – for emergency use. According to NITI Aayog Member Dr VK Paul, India has six vaccine clinical trials that are currently going on in the country.

About Moderna vaccine

The Moderna vaccine is based on mRNA technology and evidence from its clinical trials for its COVID-19 vaccine shows that it was 94 percent effective at preventing lab-confirmed COVID-19 in people who were given two doses and had no history of the infection. Moderna's vaccine candidate 'mRNA-1273' is believed to offer protection against the virus for 'several months' according to World Health Organisation (WHO) but according to the company's CEO Stephane Bancel, immunity against the vaccine can last for a couple of years.

The vaccine is given in two doses 28 days apart and can be extended to 42 days. It has shown to be effective around 14 days after one receives the first dose. The vaccine needs to be kept frozen between -25°C and -15°C, which is similar to a normal freezer if it’s not being used immediately. Each vial contains enough doses to vaccinate 10 people. According to a Time report, the vaccines needs to be thawed before it is used and once thawed, the unopened vial needs to be used within 30 days. Once a vial is punctured, it needs to be used within six hours.

The vaccine was not tested in pregnant or breastfeeding women and more studies need to be conducted to know if it is safe for them. The US's Centre for Disease Control (CDC) said it is a woman's personal choice. The vaccine is also not supposed to be given to children under the age of 18 years as those studies are needed to be conducted as well.

According to the clinical trial data, WHO says the vaccine is safe and effective in people with known medical conditions hypertension, diabetes, asthma, pulmonary, liver or kidney disease, as well as chronic infections that are stable and controlled.

The most common side effects, according to the CDC, from getting the vaccine are pain in the arm you got the shot along with swelling and redness. Other effects throughout the body are chills, tiredness and headache.



from Firstpost Tech Latest News https://ift.tt/2Ml0Eud

Sixteen Chinese COVID-19 vaccines undergoing clinical trials for national, global supply

As the demand for the COVID-19 vaccine intensified around the world, China said that it has increased the number of vaccines undergoing clinical trials to 16 from 11 to step up supplies at home and abroad. China is conducting clinical trials of 16 COVID-19 vaccines, seven of which have entered phase-III trials and one has conditionally hit the market, Wu Yuanbin, an official with the Ministry of Science and Technology, was quoted as saying by the state-run CGTN TV.

Wu made the comments during a haematology conference on Saturday.

Yang Sheng, Deputy Director of China's National Medical Products Administration's drug registration bureau, said last month that a total of 11 Chinese vaccine candidates are in different stages of testing at home and abroad.

Currently, China is vaccinating people at home and some countries abroad with two vaccines. The Chinese government has given conditional approval to Sinopharm while the results of the phase-3 trial is yet to be released.

The World Health Organisation (WHO) is reviewing the trials of both the vaccines.

China has said that so far 46 countries have expressed their desire to import the China-made vaccines.

Respiratory-disease expert Zhong Nanshan said on Sunday that the mass inoculation of homegrown COVID-19 vaccines underway in China shows the vaccines are safe and effective.

The two vaccines currently in use in China – the China National Biotec Group (CNBG) COVID-19 vaccine and the CoronaVac vaccine developed by China's Sinovac Biotech Ltd – are both inactivated vaccines that are relatively safe, Zhong said at the launch ceremony of an event in south China's Guangdong province.

According to the Chinese Centre for Disease Control and Prevention (China CDC), more than 24 million doses of the COVID-19 vaccine had been administered in China till Sunday, state-run Xinhua news agency reported.

"The rate of the vaccines' mild adverse reactions, which include fever, soar arms and other symptoms, is six per 100,000 people," Zhong said.

The rate of severe adverse vaccine reactions is one in a million, only one third of that of flu vaccines, he said.



from Firstpost Tech Latest News https://ift.tt/3pB5gut

NASA, crew, astronaut families pay homage to the fallen on 35th anniversary of the Challenger disaster

NASA leaders, retired launch directors, families of fallen astronauts and space fans marked the 35th anniversary of the Challenger disaster on Thursday, vowing never to forget the seven who died during liftoff. The pandemic kept this year’s remembrance more muted than usual. Barely 100 people — all masked and seated or standing far apart — gathered in front of Kennedy Space Center’s Space Mirror Memorial. The late morning ceremony was held almost exactly the same time as the accident shortly after liftoff on 28 January 1986.

NASA lost seven of its own on the morning of Jan. 28, 1986, when a booster engine failed, causing the Shuttle Challenger to break apart just 73 seconds after launch. In this photo from Jan. 9, 1986, the Challenger crew takes a break during countdown training at NASA's Kennedy Space Center. From left to right are Teacher-in-Space Christa McAuliffe and astronauts Gregory Jarvis, Judith Resnik, Mission Commander Dick Scobee, astronaut Ronald McNair, pilot Mike Smith, and astronaut Ellison Onizuka. Image Credit: NASA

Among the attendees: Donna Smith, visiting from Florida’s Gulf Coast to “make sure they’re never forgotten.” She was a high school student when the crew was lost; the sky was so clear that frigid morning that she could see the doomed launch all the way across the state.

The widow of Challenger commander Dick Scobee quietly observed the anniversary from her home in Chattanooga, Tennessee. In a recent interview, June Scobee Rodgers said the presence of teacher Christa McAuliffe on the flight added to the crew’s lasting legacy. Scobee Rodgers, herself a longtime educator, said her husband was assigned the teacher-in-space flight because of her own career. NASA figured “he would have compassion for a teacher,” she told The Associated Press.

A social studies teacher in Concord, New Hampshire, McAuliffe was going to perform experiments and offer lessons from space.

Scobee Rodgers helped establish the Challenger Center for Space Science Education in the wake of the accident, along with the other Challenger families. She said that helped all of them heal and “move forward.”

“In their loss, somehow, their mission continues in many, many different ways,” she said.

Flags flew half-staff at NASA centres around the country Thursday, with small ceremonies also held at Johnson Space Center in Houston and Arlington National Cemetery in Virginia. The US Mint is offering a new commemorative silver dollar honouring McAuliffe.

This year’s observance focused on the Challenger crew — McAuliffe, Scobee, Michael Smith, Judith Resnik, Ellison Onizuka, Ronald McNair and Gregory Jarvis. But it also paid tribute to the 18 others whose names are carved into the massive granite mirror at Kennedy’s visitor complex.

Seven were killed during reentry aboard shuttle Columbia on 1 February 2003. Three died in the Apollo 1 fire on the launch pad on 27 January 1967. Another was killed in a Virgin Galactic test flight in 2014. Plane crashes claimed the rest.

“We honour these heroes and remind ourselves of the lessons that the past continues to teach us,” said Kennedy’s deputy director, Janet Petro.

Petro noted that SpaceX is now flying astronauts to the International Space Station for NASA, and more new spaceships are on the horizon. Many of the newcomers were not around for the shuttle accidents, she said, and so the hard lessons must be shared.

Poor management and a stifling culture contributed to both shuttle accidents. Challenger was brought down by eroded O-ring seals in the right solid rocket booster, Columbia by a chunk of foam insulation that broke off the fuel tank at liftoff and pierced the left-wing.

Retired launch director Mike Leinbach — who was at Kennedy for both shuttle tragedies — said his one wish is for no more names to be added to the memorial.

“It’s already too full.”



from Firstpost Tech Latest News https://ift.tt/36r7ftJ

Xiaomi files a lawsuit seeking to overturn former Trump administration's blacklisting

Xiaomi says on Sunday it has filed a lawsuit seeking to overturn the former Trump administration's last-minute blacklisting of the electronics giant. Xiaomi said it filed the appeal with a Washington federal court Friday after former president Donald Trump's administration barred investment in the firm, saying the Beijing-headquartered company was a part of the Chinese military. Xiaomi said it "believes that the decision ... was factually incorrect and has deprived the company of legal due process."

"With a view to protect the interest of its global users, partners, employees and shareholders, Xiaomi Corporation has filed proceedings in the United States District Court for the District of Columbia against the Department of Defense and Department of Treasury of the United States, for listing the company as “Communist Chinese Military Company," the statement added.

Representational image: Reuters

Just six days before Trump left office, his officials made a series of announcements targeting Xiaomi and other Chinese firms including state oil giant CNOOC and embattled social media favourite TikTok.

Xiaomi – which overtook Apple last year to become the world's third-largest smartphone manufacturer – was one of nine firms the Pentagon classified as "Communist Chinese military companies." As per the executive order signed by Trump, after the ban, US investors had to divest their stakes in Chinese companies on the military list by November 2021.

The measure was seen as an attempt to cement Trump's trade war legacy with China after four years of turbulent relations with Beijing.

The blacklisting means US investors cannot buy Xiaomi securities.

The company's stock price dropped more than 10 percent following the blacklisting.

With inputs from AFP



from Firstpost Tech Latest News https://ift.tt/3anBjaW

Netflix is currently testing a timer feature for Android devices: Report

Netflix, for Android devices, could soon be getting a new time feature. The company has been testing a sleep timer that would stop the video playback on its own, after a set time limit. This story is available on The Verge website. This new feature will allow users to choose between four timer settings that include a 15 minutes timer, 30 minutes timer, 45 minutes timer, or end of whatever they are watching. As soon as the time limit comes to an end the app would automatically stop.

netflix-logo1280

Theoretically, this feature will aid in saving battery in Android devices, while making sure that the episodes don't continue via auto-play.

For now, the test is limited to selected Android users but Netflix could bring this feature to other devices like desktops, TV sets, depending on how widely the product is used.

[hq]How to use the timer feature on Android devices[/hq]

[hans][hstep]Step 1:Select your favorite TV show or movie on your mobile device[/hstep]

[hstep]Step 2: Users will see a clock icon on the upper right labeled as Timer[/hstep]

[hstep]Step 3: Click on the Timer[/hstep]

[hstep]Step 4: Now select from the 15, 30, 45 minutes, or Finish Show options[/hstep][/hans]

The feature, for now, is only available for adult profiles. The new screen time option feature could be a great option for kids too and the company could potentially make a version of the same or account profiles designed for children, depending on how well the feature is received. Instead of tapping on the clock icon and setting the timer, the feature for kids should be tweaked a little, as kids tend to tap on screens frequently.

This seems like a pretty cool feature, especially if you are someone, who falls asleep watching Netflix or other content on the phone. Having a turn-off option when an episode ends seems like a great feature.



from Firstpost Tech Latest News https://ift.tt/2NIsaC7

Maine-based bluShift aerospace successfully launches prototype rocket in test flight

A Maine company that’s developing a rocket to propel small satellites into space passed its first major test on Sunday. Brunswick-based bluShift Aerospace launched a 20-foot (6-meter) prototype rocket, hitting an altitude of a little more than 4,000 feet (1,219 meters) in a first run designed to test the rocket’s propulsion and control systems. It carried a science project by Falmouth High School students that will measure flight metrics such as barometric pressure, a special alloy that’s being tested by a New Hampshire company — and a Dutch dessert called stroopwafel, in an homage to its Amsterdam-based parent company.

Organizers of the launch said the items were included to demonstrate the inclusion of a small payload.

The company, which launched from the northern Maine town of Limestone, the site of the former Loring Air Force Base, is one of dozens racing to find affordable ways to launch so-called nano satellites. Some of them, called Cube-Sats, can be as small as 10 centimeters by 10 centimeters.

On 31 January 2021, an unmanned bluShift Aerospace rocket lifted off in a test run in Limestone, Maine. It was the first commercial rocket launch in Maine history. Image: The Knack Factory/bluShift Aerospace via AP

Sascha Deri, chief executive officer of bluShift, said the company is banking on becoming a quicker, more efficient way of transporting satellites to space.

“There’s a lot of companies out there that are like freight trains to space,” Deri said. “We are going to be the Uber to space, where we carry one, two or three payloads profitably.”

Another aspect that makes bluShift’s rocket different is its hybrid propulsion system.

It relies on a solid fuel and a liquid oxidizer passing either through or around the solid fuel; the result is a simpler, more affordable system than a liquid fuel-only rocket, said spokesperson Seth Lockman. The fuel is a proprietary biofuel blend sourced from farms, Deri said.

“It’s a very nontoxic fuel, I like to say that I could give it to either one of my little daughters. Nothing bad would happen to them, I swear,” he said. “So it’s very much nontoxic. It’s carbon neutral.”

The goal is to create a small rocket that could launch a 30-kilogram (66-pound) payload into low-Earth orbit, more than 100 miles (160 kilometers) above Earth’s surface. Lockman said orbit could be possible by 2024.

The company has spent $800,000 on research and development, with some of the money coming from NASA.

Representatives from bluShift said they don’t anticipate being able to launch from Brunswick, where they are headquartered, because of population density in the area.

An attempted test launch in Limestone earlier in January was postponed because of weather. Sunday’s launch was also held back by a couple of false starts, but event organizers described the eventual 3 p.m. liftoff as “perfect.”



from Firstpost Tech Latest News https://ift.tt/2MFg0th

Poco M3 with a 6,000 mAh battery to launch in India tomorrow: All we know so far

Poco has officially announced on Twitter and has sent out invites for the Poco M3 launch tomorrow (2 February). Poco has released a teaser video revealing that the smartphone houses a huge rectangular camera module at the back. It is also confirmed that Poco M3 will be available in black, blue and yellow colour options. Poco M3 had previously debuted in globally last year in November. The India launch will take place at 12 pm tomorrow.

Poco M3

Poco M3 expected specifications

Going by the global variant, Poco M3 will feature a 6.53-inch full-HD+ display that comes with 1,080 x 2,340 pixels resolution. It is likely to be powered by Snapdragon 662 chipset and offers 4 GB RAM and up to 128 GB of internal storage. It is expected to be powered by MIUI 12 based on Android 10. It will also feature a side-mounted fingerprint sensor.

For photography, it might sport a triple rear camera setup that houses a 48 MP primary sensor, a 2 MP secondary sensor and a 2 MP depth sensor. For selfies, it might come with an 8 MP front camera.

As for the battery, it is likely to be equipped with a 6,000 mAh battery that supports 18 W fast charging.



from Firstpost Tech Latest News https://ift.tt/3cpj33L

Top 5 cryptocurrencies to watch this week: BTC, ETH, UNI, ATOM, COMP

Bitcoin price fell back into the descending triangle but this dip may attract buyers to altcoins and DeFi tokens in the short term.



from Cointelegraph.com News https://ift.tt/3aqTblw

Navigating the World of Crypto: Exploring the Potential of Crypto4u

 In recent years, the world of cryptocurrency has undergone a seismic shift, evolving from a niche interest among tech enthusiasts to a glob...